William Pollack

Title: The Innovations of William Pollack

Introduction

William Pollack is an accomplished inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of medical science, particularly in the treatment of neoplastic diseases and hepatitis B virus disease. With a total of 2 patents, Pollack's work has the potential to impact the lives of many patients.

Latest Patents

Pollack's latest patents include a process for aiding the regression and palliation of neoplastic disease in both animal and human hosts. This innovative method involves the systemic administration of phenylimidazo[2,1-b]thiazole or a nontoxic acid addition salt thereof. The active ingredient is preferably administered in dosages ranging from about 1 mg to about 5 mg/kg of body weight of the host. Another notable patent describes a method for producing a novel immunizing agent against hepatitis B virus disease. This immunizing agent is anti-HBs gamma globulin, which is essentially free of fibrinogen, plasminogen, 19 S globulin, and lipids. The production method involves fractionation of human plasma utilizing selective solvent and control of pH, temperature, and ionic strength.

Career Highlights

Throughout his career, Pollack has worked with reputable companies such as Ortho Diagnostics, Inc. and Janssen Pharmaceutica NV. His experience in these organizations has contributed to his expertise in the field of medical innovations.

Collaborations

Pollack has collaborated with notable coworkers, including Albert McKee and Josephus Brugmans. These partnerships have likely enriched his research and development efforts.

Conclusion

William Pollack's contributions to medical science through his patents and collaborations highlight his dedication to improving health outcomes. His innovative approaches to treating neoplastic diseases and hepatitis B virus disease demonstrate the importance of research and development in the medical field.